Sign Out
Fosphenytoin sodium (Aurantin) is indicated for short-term parenteral administration when other means of phenytoin administration are unavailable, inappropriate or deemed less advantageous. The safety and effectiveness of fosphenytoin sodium (Aurantin) in this use have not been systematically evaluated for more than 5 days.
Fosphenytoin sodium (Aurantin) can be used for the control of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery. Parenterally administered fosphenytoin sodium (Aurantin) can be substituted, short-term, for oral phenytoin.
